Cardiovascular Research

Papers
(The H4-Index of Cardiovascular Research is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Global burden of heart failure: a comprehensive and updated review of epidemiology924
Cardiac fibrosis540
Vascular smooth muscle cells in atherosclerosis: time for a re-assessment214
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome133
Neutrophil extracellular traps: from physiology to pathology131
Senescence mechanisms and targets in the heart124
Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets110
Environmental risk factors and cardiovascular diseases: a comprehensive expert review109
NLRP3 inflammasome as a key driver of vascular disease104
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute Card102
mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification101
Obesity, kidney dysfunction, and inflammation: interactions in hypertension97
The role of CD36 in cardiovascular disease95
Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart92
NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias85
Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working 82
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes74
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications73
Inflammation during the life cycle of the atherosclerotic plaque73
Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function70
The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis69
Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis66
Physiological and pathological roles of protein kinase A in the heart66
Soil and water pollution and human health: what should cardiologists worry about?65
Risk factors profile of young and older patients with myocardial infarction64
Emerging views of statin pleiotropy and cholesterol lowering64
Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications63
Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases63
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis62
Transthyretin cardiac amyloidosis61
Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles60
Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension60
Dietary recommendations for prevention of atherosclerosis59
From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?59
Titin (TTN): from molecule to modifications, mechanics, and medical significance55
Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank55
Relationship between lipoproteins, thrombosis, and atrial fibrillation54
Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction53
Cell therapy in patients with heart failure: a comprehensive review and emerging concepts53
Association of cardiometabolic microRNAs with COVID-19 severity and mortality52
Computational models of atrial fibrillation: achievements, challenges, and perspectives for improving clinical care50
Regenerative potential of epicardium-derived extracellular vesicles mediated by conserved miRNA transfer49
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice48
Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis47
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart47
Myocardin-related transcription factor A regulates integrin beta 2 transcription to promote macrophage infiltration and cardiac hypertrophy in mice47
The role of autophagy in cardiovascular pathology46
How machine learning is impacting research in atrial fibrillation: implications for risk prediction and future management46
0.17684412002563